Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence Ashish Singhal, Muralidharan Jayaraman, Danny.

Slides:

Advertisements

Similar presentations

MicroRNA Profiling of Laser-Microdissected Hepatocellular Carcinoma Reveals an Oncogenic Phenotype of the Tumor Capsule Jan Peveling-Oberhag, Anna Seiz,

Advertisements

Gastric cancer Critical Reviews in Oncology / Hematology

Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi

Critical Reviews in Oncology / Hematology

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review Cloé Brami, Ting Bao, Gary Deng Critical.

Novel targets in gastric and esophageal cancer

Critical Reviews in Oncology / Hematology

Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions? Séverine Guiu, Anita Wolfer, William Jacot, Pierre.

MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma

The case for wider use of recombinant factor VIII concentrates

P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature Omar Abdel-Rahman,

Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey Lazzaro Repetto Critical.

The see-saw of Keap1-Nrf2 pathway in cancer

Genistein: Its role in metabolic diseases and cancer

Abhimanyu Ghose, Ria Kundu, Tahir Latif

P. Therasse, S. Carbonnelle, J. Bogaerts

Olfa Baroudi, Amel Benammar-elgaaied

Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward

Critical Reviews in Oncology / Hematology

Primary renal carcinoid: Treatment and prognosis

PUBLISH ONLY Journal of Thoracic Oncology

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello Critical.

Gerhard J. Molderings Critical Reviews in Oncology / Hematology

Volume 149, Issue 4, Pages (October 2015)

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials Pippa Newell, Augusto Villanueva, Josep M. Llovet

Volume 152, Issue 5, Pages (April 2017)

Volume 149, Issue 4, Pages (October 2015)

Andrea L Kasinski, Frank J Slack Molecular Therapy - Nucleic Acids

Lymphotoxins: New Targets for Hepatocellular Carcinoma

Jean-Charles Nault, Jessica Zucman-Rossi Journal of Hepatology

Dan Gordon Gastroenterology Volume 114, Issue 4, (April 1998)

Florie Borel, Pavlina Konstantinova, Peter L.M. Jansen

Hepatitis B and C virus-related carcinogenesis

Biology and Clinical Applications of Pancreatic Cancer Stem Cells

Volume 65, Issue 4, Pages (October 2016)

Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt

Apoptosis-targeted therapies for cancer

Targeting gut flora to prevent progression of hepatocellular carcinoma

Volume 6, Issue 3, Pages (September 2004)

Quiescence regulators for hematopoietic stem cell

Keiran S.M. Smalley Journal of Investigative Dermatology

Volume 145, Issue 1, Pages (July 2013)

LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis

miR-34a and the Cardiomyopathy of Senescence: SALT PNUTS, SALT PNUTS!

Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn

Experimental Hematology

Hepatitis B and C virus-related carcinogenesis

PUBLISH ONLY Journal of Thoracic Oncology

Molecular prognostication of liver cancer: End of the beginning

Targeted Therapies for Hepatocellular Carcinoma

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

Notch Signaling in Hepatocellular Carcinoma: Guilty in Association!

TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling Sarah T.K. Sin, Yan Li, Ming Liu, Stephanie.

Evolution of liver transplantation for hepatocellular carcinoma

Mitotic Inhibitors Journal of Thoracic Oncology

The Dual Role of Bone Morphogenetic Proteins in Cancer

Apoptosis-targeted therapies for cancer

Long Noncoding RNAs and Hepatocellular Carcinoma

Covering the Cover Gastroenterology

Genetics of hepatocellular carcinoma: The next generation

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

Neal S Goldstein, MD The Annals of Thoracic Surgery

Volume 23, Issue 6, Pages (June 2013)

Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in a Small Animal Model Neoadjuvant PI3K/mTOR/AKT inhibitor prior.

Matthew I. Stein, Jiang Zhu, Stephen G. Emerson

CLE and RGF Family Peptide Hormone Signaling in Plant Development

Volume 142, Issue 7, Pages (June 2012)

Genotype–Phenotype Relationships in Hepatocellular Carcinoma: p53 Inactivation Promotes Tumors With Stem Cell Features Jean–Charles Nault, Jessica Zucman–Rossi

Presentation transcript:

Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli Critical Reviews in Oncology / Hematology Volume 82, Issue 2, Pages 116-140 (May 2012) DOI: 10.1016/j.critrevonc.2011.05.005 Copyright © 2011 Terms and Conditions

Fig. 1 MicroRNAs as biomarkers involved in survival, proliferation, and invasion of HCC. MicroRNA regulates the expression of various proteins involved in various signaling pathways including apoptosis, cell-cycle check point, transcription factors, phosphatases, oncogenes, and many more. Critical Reviews in Oncology / Hematology 2012 82, 116-140DOI: (10.1016/j.critrevonc.2011.05.005) Copyright © 2011 Terms and Conditions

Fig. 2 Molecular markers involved in hepatocarcinogenesis and tumor metastasis. Critical Reviews in Oncology / Hematology 2012 82, 116-140DOI: (10.1016/j.critrevonc.2011.05.005) Copyright © 2011 Terms and Conditions